JCRB0163 HL60(S)
Cell information
Cell type:general cells (View Pricing Information)
JCRB No. | JCRB0163 | Cell Name | HL60(S) |
---|---|---|---|
Profile | Promyeloblastic cell line differentiated to neutrophils or macropahges by tumor promoters, vitamne D3 or cytekines. This HL60(S) has been independently obtained by Dr. Ishida,S. and Dr. Shudo,K. | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | F | Age | 36 |
Identity | available | Tissue for Primary Cancer | hemo-lymphocytic |
Case history | acute promyelotic leukemia | Metastasis | |
Tissue Metastasized | Genetics | APL | |
Life Span | infinite | Crisis PDL | |
Morphology | lymphocyte-like | Character | DMSO, butyl, HX., TPA, active vitamine D3, and Retinoic Acid induce differentiation efficiently. |
Classify | tumor | Established by | Collins,S.J. et al. |
Registered by | Shudo,K. | Regulation for Distribution | free |
Comment | STR-PCR results indicated the HL60(S) is the same with HL60(JCRB0085) | Year | 2000 |
Medium | RPMI1640 medium with 5% fetal bovine serum (heat inactivation may be done). | Methods for Passages | Simple dilution. Subculture every 3 days. |
Cell Number on Passage | 1 x 10^5 cells/ml | Race | Cocasian |
CO2 Conc. | 5 % | Tissue Sampling | peripheral blood |
Tissue Type |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Reference | |
---|---|
Pubmed id:7944409 | Induction of differentiation and covalent binding to proteins by the synthetic retinoids Ch55 and Am80. Takahashi N,Breitman TR Arch Biochem Biophys. 1994 Oct;314(1):82-9 |
Pubmed id:3184125 | Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity. Kagechika H,Kawachi E,Hashimoto Y,Himi T,Shudo K J Med Chem. 1988 Nov;31(11):2182-92 |
Pubmed id:6192693 | Fundamentals of chemotherapy of myeloid leukemia by induction of leukemia cell differentiation. Hozumi M Adv Cancer Res. 1983;38():121-69 |
Pubmed id:288488 | Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Gallagher R,Collins S,Trujillo J,McCredie K,Ahearn M,Tsai S,Metzgar R,Aulakh G,Ting R,Ruscetti F,Gallo R Blood. 1979 Sep;54(3):713-33 |
Pubmed id:271272 | Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Collins SJ,Gallo RC,Gallagher RE Nature. 1977 Nov 24;270(5635):347-9 |
Images |
---|
LOT Information
Cell No. | JCRB0163 | Cell Name | |
---|---|---|---|
LOT No. | 07292004 | Lot Specification | distribution |
Medium | RPMI1640 medium with 10% fetal bovine serum. At log growth phase, serum contents can be decreased to 5%. (FBS lot; GIBCO 3762782S) | Temperature | 37 C |
Cell Density at Seeding | 7-10 x 10^4 cells/ml | Methods for Passages | dilution |
Doubling Time | 21 hrs | Cell Number in Vial (cells/1ml) | 1.1 x 10^6 |
Viability at cell freezing (%) | 91 | Antibiotics Used | free |
Passage Number | P7 at bank | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), AST. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | No | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0163 | Cell Name | HL60(S) |
---|---|---|---|
LOT No. | 04192001 | Lot Specification | distribution |
Medium | RPMI1640 medium with 10 or 20% heat inactivated fetal bovine serum (Intergen RB52405). | Temperature | 37 C |
Cell Density at Seeding | 2.0 x 10^5 cells/ml | Methods for Passages | Simple dilution. split ratio=1/4. Subculture every 3-4 days. |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 1.8 x 10^6 |
Viability at cell freezing (%) | 94.1 | Antibiotics Used | free |
Passage Number | P3* | PDL | NT |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NT |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | |
Adhesion | No | Exoteric Gene | NT |
Medium for Freezing | Culture medium containing 5 % DMSO. | CO2 Conc. | 5 % |
Viability immediately after thawing (%) | Additional information |
Images |
---|
Cell No. | JCRB0163 | Cell Name | HL60(S) |
---|---|---|---|
LOT No. | 04112017 | Lot Specification | distribution |
Medium | RPMI 1640 medium with 10 - 20% fetal bovine serum. At log growth phase, serum contents can be decreased to 5%. (FBS; Sigma Cat. # 172012) | Temperature | 37 C |
Cell Density at Seeding | approx. 1 x 10^5 cells/ml | Methods for Passages | Simple dilution (suspension culture). |
Doubling Time | approx. 18 hrs. | Cell Number in Vial (cells/1ml) | 2.8 x 10^6 |
Viability at cell freezing (%) | 88.1 | Antibiotics Used | free |
Passage Number | Unknown (6 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | No | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 88.1 | Additional information |
Cell No. | JCRB0163 | Cell Name | HL60(S) |
---|---|---|---|
LOT No. | 10212022 | Lot Specification | distribution |
Medium | RPMI1640(GIBCO Cat#11875-093) with 10% heat inactivated fetal bovine serum (SIGMA, Cat#172012, Lot#12J396) | Temperature | 37 C |
Cell Density at Seeding | 1.76-3.0x10^4 cells/ml | Methods for Passages | dilution |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 2.68x10^6 |
Viability at cell freezing (%) | 84 | Antibiotics Used | free |
Passage Number | p6* | PDL | NT |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | D5S818:12 D13S317:8,11 D7S820:11,12 D16S539:11 VWA:16 TH01:7,8 AM:X TPOX:8,11 CSF1PO:13,14 |
Adhesion | No | Exoteric Gene | NT |
Medium for Freezing | BAMBANKER (LYMPHOTEC Inc., CS-02-001, NIPPON Genetics Co., LTD) | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 90 | Additional information |
Images |
---|